Of note, OXCT1 was significantly increased in the human donor progressing on ADT therapy (castrate resistant) and on MDA PCa 203, the longitudinal sample of MDA PCa 183, derived from the same human donor after relapse (castration resistant). The gene discussed is OXCT1; the disease is posterior cortical atrophy.